Smart Inhalers market revenue is estimated to be $XX Billion in 2019 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.
Smart Inhalers are developed by adding digital features to regular inhalers to make the ownership of an inhaler much easier for the user. This is done by digital functionalities such as sensors to alert the user of a high-pollution area, feedback on inhaler usage technique, and to track the dosage.
Analysis by Product
According to the Product, the main segments are Dry Powder Inhaler (DPI)- based smart inhalers and Metered Dose Inhaler (MDI)- based smart inhalers. One of the Smart Inhalers market report asserts that the DPI-based smart inhalers will show double-digit growth in the upcoming period. This is because of a collaboration of digital companies with Pharmaceutical organizations to introduce an add-on sensor which is compatible with DPI-based inhalers. Another Smart Inhalers research indicates that these products are getting connected to mobile applications to provide vital information to users in a digital form. A fair portion of the Smart Inhalers market share is also catered to by MDI-based Smart Inhalers. Strategic partnerships are likely to play a defining role in the growth of this segment in the forecasted period.
Analysis by Disease Indication
According to Disease indication, the segments are Chronic Obstructive Pulmonary Disease (COPD) and Asthma. The Smart Inhalers market size of the Asthma segment has grown into a multi-million-dollar industry and has the potential to harness much larger market capitalization over this period. This is because Asthma is one of the most common and prevalent chronic airway diseases. On the other hand, the Smart Inhalers market estimation suggests a strong runway ahead for the COPD segment as well. The estimates of double-digit growth have been indicated.
Analysis by Distribution Channel
The distribution channels can be segmented into Hospital Pharmacies, Retail Pharmacies, and E-commerce. Hospital pharmacies have been the most preferred procurement option among consumers owing to its suitable location. The eco-system in the hospital is that of trust and Smart Inhalers are strategically distributed through these centers. Accessibility is this segment’s competitive advantage over the other two. Conversely, the Smart Inhalers market forecast is looking very encouraging for Retail pharmacies as well. Growing government approvals for Smart Inhaler commerce from Retail pharmacies will positively boost the segment performance. Tactical partnerships between retailers and smart inhaler manufacturers will result in unlocking sales synergies for this product.
Analysis by Region
The North American region houses some of the world’s most health-conscious population. Their spending affinity towards advanced health-care devices will augment the multi-million-dollar industry further. The Smart Inhaler price trend is surely developing into a very favorable business scenario for the companies involved. The Asia-Pacific is picking up pace in the sales of Smart Inhalers as well owing to increasing disposable incomes in this region. The Smart Inhaler companies are eyeing this as a very promising business environment for the forecasted period.
Analysis by Distinguished Companies
Some eminent organizations in this space are AstraZeneca plc, GlaxoSmithKline, Aptar Pharma, Novartis, Teva Pharmaceuticals, H&T Presspart Manufacturing Ltd., Findair Sp. z o. o., and Zeolr Technologies Pvt Ltd. The pillar of success in this industry will be the partnerships between Digital companies and Pharmaceutical Organizations. Innovation of suitable features from the digital end will aid the prosperity of Smart Inhalers in a big way. In certain cases, smaller Digital companies will be acquired by larger Pharmaceutical organizations to augment their product growth and adoption. Other industries in this domain that are growing at a high CAGR include Smart Scale Market and Smart Materials Market.
COVERAGE HIGHLIGHTS
● Market Revenue Estimation and Forecast (2019 – 2026)
● Market Production Estimation and Forecast (2019 – 2026)
● Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
● Breakdown of Revenue by Segments (2019 – 2026)
● Breakdown of Production by Segments (2019 – 2026)
● Breakdown of Sales Volume by Segments (2019 – 2026)
● Gross Margin and Profitability Analysis of Companies
● Business Trend and Expansion Analysis
● Import and Export Analysis
● Regional Analysis and Market Data Breakdown
MARKET SEGMENTATION
By Product Outlook ($Revenue and Unit Sales, 2019-2026)
• Dry Powder Inhaler (DPI)- based smart inhalers
• Metered Dose Inhaler (MDI)- based smart inhalers
By Disease Indication Outlook ($Revenue and Unit Sales, 2019-2026)
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
By Distribution Channel Outlook ($Revenue and Unit Sales, 2019-2026)
• Hospital Pharmacies
• Retail Pharmacies
• E-commerce
By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
• U.S.
• Canada
• Germany
• U.K.
• France
• Spain
• Italy
• Japan
• China
• India
• Australia
• Brazil
• Mexico
• South Africa
• Turkey
• Saudi Arabia
Distinguished Companies
• AstraZeneca plc
• GlaxoSmithKline
• Aptar Pharma
• Novartis AG
• Boehringer Ingelheim
• Teva Pharmaceuticals
• H&T Presspart Manufacturing Ltd.
• Findair Sp. z o. o.
• Vectura Group
• Zeolr Technologies Pvt Ltd
